Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Lymphoma
Interventions: DRUG: Ad-p53
Sponsor: MultiVir, Inc.